News Releases

Biotech Showcase 2016 Reports Record High Attendance This Year

CARLSBAD, Calif., and NEW YORK and SAN FRANCISCO, Jan. 27, 2016 /PRNewswire/ -- A record number of life science industry executives attended the eighth annual Biotech Showcase™ investor and networking conference, held January 11–13 in San Francisco.

More than 2,500 executive-level delegates representing qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives attended from 1,600 companies and participated in 5,650 one-to-one investor meetings.

Over 300 innovative company presentations took place featuring mid-small cap and private life sciences across the therapeutic spectrum as well as platform, diagnostic and tool companies hoping to pique the interest of the nearly 600 public, private and strategic investors in attendance. As well, special presentation tracks were included in two new one-day events within Biotech Showcase, Medtech Showcase and Digital Health Showcase.

"The widespread commercialization of the biotech industry presented life sciences investors and industry leaders with new opportunities and challenges this year as they gathered for this year's Biotech Showcase. We are proud that the event has become a home base for the life sciences industry during the healthcare industry's busiest week of the year," said Sara Jane Demy, CEO of Demy-Colton Life Science Advisors.

"Although 2015 has been a volatile year for biotech, Biotech Showcase attendance is at an all time high. This speaks to the sustained interest within the investor community in biotech innovation," said Anna Chrisman, Group Managing Director, EBD Group. "This year we provided more space, more one-on-one meetings which we hope resulted in more opportunities. It was overwhelmingly successful."

Biotech Showcase is produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of producing high quality programs supporting the biotechnology and broader life sciences industry.

Biotech Showcase is powered by partneringONE®, the industry's most advanced meeting system that enables delegates to efficiently identify and arrange meetings with potential investors.

Up-to-date coverage of Biotech Showcase, including panel videos and interviews, can be found on the Biotech Showcase website, on partnering360:Insight, and on the partnering360 Blog.

The next edition of Biotech Showcase will be held January 9–11, 2017 in San Francisco.

About  EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations and include:

EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit

About Demy-Colton Life Science Advisors
Demy-Colton Life Science Advisors is focused exclusively on facilitating the growth of the life science industry. Demy-Colton has developed a number of high-value added conferences to address the business and development needs of the biotechnology industry; it provides partnering services and it has helped launch a unique investor website and newsletter.
Demy-Colton's conferences include:

Demy-Colton's online partnering system, Networking2™, supports Demy-Colton's events and facilitates investor and venture meetings for the pharma industry and partnering for other organizations.

For more information please visit



For further information: Andrew W. Mielach, Vice President, Tiberend Strategic Advisors, Inc., Direct 212-375-2694,; Erin Righetti, EBD Group, +1 760 930 0500,